久久国产精品午夜一区_91精品國產高清久久久久久91_?级毛片免费全部播放_欧美色图在线视频一区二区三区_国产综合亚洲一区二区三区_中文字幕熟女网_国产精品男人爽免费视频_九九无码网战_亚洲日本三级电影在线观看_欧美日韩DVD手机在线不卡

上海源葉生物科技有限公司

主營產品: S30260異硫氰酸胍,30259鹽酸胍,嗜熱菌蛋白酶

15

聯系電話

15921386130

您現在的位置: 上海源葉生物科技有限公司>>小分子化合物>>小分子抑制劑>> S81193

公司信息

人:
何小姐
話:
86-021-61559134
機:
15921386130
真:
86-021-55068248
址:
上海市松江區長塔路465號6幢
編:
200433
址:
www.shyuanye.com
鋪:
http://www.mcstair.com/st191837/
給他留言
S81193
S81193
參考價 面議
具體成交價以合同協議為準
  • 型號
  • 品牌
  • 廠商性質 生產商
  • 所在地

更新時間:2025-05-15 19:44:05瀏覽次數:169

聯系我們時請說明是化工儀器網上看到的信息,謝謝!

【簡單介紹】
提示:詳情請下載說明書
  • 提示:詳情請下載說明書。
  • 產品描述:

     MI-2 MALT1 inhibitor, also known as MI-2, is a MALT1 inhibitor (IC50 = 5.84 μM). MI-2 binds directly to MALT1 and irreversibly suppresses protease function. Decreases NF-κB activity induced by MALT1. Mucosa-associated-lymphoid-tissue lymphoma-translocation gene 1 (MALT1), a paracaspase and essential regulator for nuclear factor kB (NF-κB) activation, plays an important role in innate and adaptive immunity. Suppression of MALT1 protease activity with small molecule inhibitors showed promising efficacies in subtypes of B cell lymphoma and improvement in experimental autoimmune encephalomyelitis model.

  • 靶點: MALT1
  • 體外研究: MALT1 inhibitor MI-2 (1-1000 nM; 48 hours) selectively suppresses MALT1-dependent DLBCL cell lines, and the GI50 in HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells is 0.2, 0.5, 0.4, and 0.4 µM, respectively.
    MALT1 inhibitor MI-2 (62-1000 nM; 24 hours) causes a dose-dependent decrease in MALT1-mediated cleavage.
  • 體內研究: MALT1 inhibitor MI-2 (25 mg/kg; i.p.; daily for 14 days) profoundly suppresses the growth of both the TMD8 and HBL-1 ABC-DLBCL xenografts.
  • 細胞實驗: Cell proliferation is determined by ATP quantification using a luminescent method and trypan blue dye exclusion. Standard curves for each cell line are calculated by plotting the cell number (determined using trypan blue) against their luminescence values, and cell number is calculated accordingly. Cell viability in drug-treated cells is normalized to their respective controls (fractional viability), and results are given as 1-fractional viability. CompuSyn software is used to determine GI25 and GI50 values.(Only for Reference) Cell lines: MALT1-independent cell lines: U2932 and HLY-1, and the two GCB-DLBCL cell lines; MALT1-dependent cell lines: HBL-1, TMD8, OCI-Ly3, and OCI-Ly10 cells.
  • 參考文獻:
    1: Fusco R, Siracusa R, D'Amico R, Cordaro M, Genovese T, Gugliandolo E, Peritore AF, Crupi R, Di Paola R, Cuzzocrea S, Impellizzeri D. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury. Int J Mol Sci. 2020 Oct 20;21(20):7761. doi: 10.3390/ijms21207761. PMID: 33092214; PMCID: PMC7589767.
    2: Wang R, Zhang H, Xu J, Zhang N, Pan T, Zhong X, Zhang H, Yin L, Yao Y, Wu Q, Li Z, Liu X, Xu K, Niu M. MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation. Front Oncol. 2020 Sep 23;10:558339. doi: 10.3389/fonc.2020.558339. PMID: 33072583; PMCID: PMC7538650.
    3: Ishikawa C, Mori N. MALT-1 as a novel therapeutic target for adult T-cell leukemia. Eur J Haematol. 2020 Oct;105(4):460-467. doi: 10.1111/ejh.13467. Epub 2020 Jul 24. PMID: 32574386.
    4: Liu X, Yue C, Shi L, Liu G, Cao Q, Shan Q, Wang Y, Chen X, Li H, Wang J, Gao S, Niu M, Yu R. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation. J Cell Mol Med. 2020 Jul;24(13):7550-7562. doi: 10.1111/jcmm.15383. Epub 2020 May 25. PMID: 32452133; PMCID: PMC7339184.
    5: Izumi K, Nishikori M, Yuan H, Otsuka Y, Nakao K, Takaori-Kondo A. Establishment and characterization of a MALT lymphoma cell line carrying an API2-MALT1 translocation. Genes Chromosomes Cancer. 2020 Sep;59(9):517-524. doi: 10.1002/gcc.22855. Epub 2020 May 6. PMID: 32348592.
    6: Dezorella N, Ashkenazi
  • 溶解度: DMSO:  ≥  46  mg/mL
    母液保存:分裝凍存,避免反復凍融;-20℃,1個月;-80℃,6個月(稀釋后溶液溫度低保存可能會析出,盡量現用現配)
    細胞實驗:先用DMSO溶解:再用培養基進行稀釋,稀釋過程建議分段進行,避免濃度變化過快導致化合物析出。若稀釋過程中出現化合物析出的情況,  可采用超聲的方法使其復溶。在稀釋時要確保工作液中  DMSO  的終濃度盡量在0.1%以下,不要超過0.5%,并設置相應濃度的DMSO對照組。
    動物實驗:先用DMSO溶解:再用水或者生理鹽水等去稀釋,稀釋過程建議分段進行,避免濃度變化過快導致化合物析出。若稀釋過程中出現化合物析出的情況,  可采用超聲的方法使其復溶。可以通過添加助溶劑來幫助溶解,比如植物油、Tween80、甘油、羧甲基纖維素鈉和PEG400等。具體方式請參考文獻。懸濁液可用于口服和腹腔注射,不會影響產品活性。
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.194 ml 10.972 ml 21.943 ml
    5 mM 0.439 ml 2.194 ml 4.389 ml
    10 mM 0.219 ml 1.097 ml 2.194 ml
    50 mM 0.044 ml 0.219 ml 0.439 ml
  • 注意:部分產品我司僅能提供部分信息,我司不保證所提供信息的性,僅供客戶參考交流研究之用。
該公司的其它相關產品查看所有產品 >>


產品對比 產品對比 二維碼 在線交流

掃一掃訪問手機商鋪

對比框

在線留言
主站蜘蛛池模板: 南华县| 湖南省| 江口县| 循化| 甘谷县| 新蔡县| 沛县| 呼和浩特市| 全南县| 于都县| 龙海市| 德化县| 怀化市| 博客| 太谷县| 江都市| 莆田市| 枞阳县| 赤峰市| 和林格尔县| 建瓯市| 西盟| 壤塘县| 淮阳县| 大田县| 长寿区| 抚远县| 芒康县| 东源县| 阿瓦提县| 襄樊市| 湘阴县| 汶上县| 镇康县| 张掖市| 昌乐县| 静海县| 广饶县| 定边县| 商都县| 黄大仙区|